Choosing the right biomaterials is part of clinical competence and is the foundation of long-term success. In addition to the clinical evidence for individual biomaterials that demonstrate their efficacy and mode of action, a sophisticated combination with biologics allows for improved handling and clinical outcome.
Recently cerabone® plus was introduced, a combination of hyaluronic acid, which is well known for its liquid binding capacity and outstanding bioactive properties (graft vascularization and improved wound healing), and the established bovine bone substitute cerabone®.
The speakers will present successful combinations of biomaterials for the daily clinical routine.
- Understand the rationale of using a comprehensive set of biomaterials: 360° botiss regeneration system.
- Learn about the properties of hyaluronic acid and how biofunctionalization affects tissue regeneration.
- Witness how “sticky bone” composed of hyaluronic acid and cerabone® facilitates clinical handling and applicability.